Themes US R&D Champions ETF (USRD) seeks to track companies that demonstrate exceptional commitment to research and development spending, focusing on U.S. firms that invest heavily in innovation and technological advancement. This thematic equity ETF targets businesses across sectors that allocate significant resources to R&D as a percentage of revenue.
How It Works
USRD employs a rules-based methodology that screens U.S. companies based on their R&D expenditure intensity, selecting firms that rank highest in research and development spending relative to their revenue or market capitalization. The fund likely uses a modified market-cap weighting approach with potential tilts toward higher R&D spenders. As a newly launched ETF from December 2023, specific rebalancing frequency and exact holdings composition details are still developing, though it focuses on innovation-driven companies across technology, healthcare, and industrial sectors.
Key Features
- Targets R&D-intensive companies that may benefit from innovation cycles and patent development over multi-year periods
- Launched in December 2023, providing exposure to a unique thematic strategy focused on corporate research investment
- Currently shows 0.00% expense ratio, though this may be promotional pricing for the new launch period
Risks
- This ETF can lose value if R&D-heavy companies underperform due to failed innovation projects or extended development timelines without revenue conversion
- Concentration in technology and healthcare sectors could amplify losses during sector-specific downturns or regulatory changes affecting innovation companies
- As a newly launched thematic ETF, it faces liquidity risks and potential tracking errors while building assets and establishing trading patterns
Who Should Own This
Best suited as a satellite holding (5-15% of equity allocation) for growth-oriented investors with 3-7 year time horizons who believe in innovation-driven returns. High risk tolerance required due to thematic concentration and new fund status. Appeals to investors seeking exposure to companies reinvesting heavily in future technologies and competitive advantages.